Moreover, HSP90α expression was higher in lung cancer patients’ serum in comparison to healthy individuals’ serum, indicating that HSP90 could be employed as a novel biomarker for the diagnosis of lung cancer [225]. This evidence concerns the gene HSP90AA1 and lung carcinoma.